ConductScience.org, home

Paper38717954

Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment.

Shornale Akter M and 9 others. Cancer Rep (Hoboken), 2024. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment. Papers, record 38717954. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38717954

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment.
PubMed
Journal
Cancer Rep (Hoboken)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.3, provisional
iCite
Revised in PubMed
2025-08-29
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shornale Akter MMost
2Uddin MHMd Helal
3Atikur Rahman SSheikh
4Hossain MAMd Arju
5Ashik MARMd Ashiqur Rahman
6Zaman NNNurun Nesa
7Faruk OOmar
8Hossain MSMd Sanwar
9Parvin AAnzana
10Rahman MHMd Habiburhttps://orcid.org/0000-0002-5068-2690

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Biomarkers, TumorMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Gene Expression ProfilingMajor topic
Humans
Female
Molecular Docking Simulation
Antineoplastic Agents
Protein Interaction Maps
MicroRNAs
Transcriptome
Gene Regulatory Networks
Signal Transduction

Source PubMed

Download CSV of topics

References87

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134059798The PTEN and ATM axis controls the G1/S cell cycle checkpoint and tumorigenesis in HER2-positive breast cancer.Cell Death Differ2021https://conductscience.org/library/papers/34059798PubMed
236313438A genomic and transcriptomic study toward breast cancer.Front Genet2022https://conductscience.org/library/papers/36313438PubMed
332269634ZNF24 is upregulated in prostate cancer and facilitates the epithelial-to-mesenchymal transition through the regulation of Twist1.Oncol Lett2020https://conductscience.org/library/papers/32269634PubMed
432462972Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.Technol Cancer Res Treat2020https://conductscience.org/library/papers/32462972PubMed
532211045Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR.J Oncol2020https://conductscience.org/library/papers/32211045PubMed
630371825PubChem 2019 update: improved access to chemical data.Nucleic Acids Res2019https://conductscience.org/library/papers/30371825PubMed
732203934Regulation of docetaxel chemosensitivity by NR2F6 in breast cancer.Endocr Relat Cancer2020https://conductscience.org/library/papers/32203934PubMed
830288111Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy.Cancer Manag Res2018https://conductscience.org/library/papers/30288111PubMed
931799611The activating transcription factor 2: an influencer of cancer progression.Mutagenesis2019https://conductscience.org/library/papers/31799611PubMed
1021217834Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.PLoS One2010https://conductscience.org/library/papers/21217834PubMed
1125618350Small-molecule library screening by docking with PyRx.Methods Mol Biol2015https://conductscience.org/library/papers/25618350PubMed
1234638457Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic.Cancers (Basel)2021https://conductscience.org/library/papers/34638457PubMed
1325521941cytoHubba: identifying hub objects and sub-networks from complex interactome.BMC Syst Biol2014https://conductscience.org/library/papers/25521941PubMed
1429449899FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles.Ther Adv Med Oncol2017https://conductscience.org/library/papers/29449899PubMed
1523586463Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool.BMC Bioinformatics2013https://conductscience.org/library/papers/23586463PubMed
1615028117VisANT: an online visualization and analysis tool for biological interaction data.BMC Bioinformatics2004https://conductscience.org/library/papers/15028117PubMed
1718790636Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors.Bioorg Med Chem Lett2008https://conductscience.org/library/papers/18790636PubMed
1814733031Breast cancer: a review of the literature.J Insur Med2003https://conductscience.org/library/papers/14733031PubMed
1925176396jvenn: an interactive Venn diagram viewer.BMC Bioinformatics2014https://conductscience.org/library/papers/25176396PubMed
2026892619Trastuzumab in the Treatment of Breast Cancer.BioDrugs2016https://conductscience.org/library/papers/26892619PubMed

See all 87 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41548001QAL333's antitumor activity and predictive modeling: integrated transcriptomic-bioinformatic analysis reveals selective cytotoxicity and sensitivity determinants.Sci Rep2026https://conductscience.org/library/papers/41548001PubMed
40907734Subtype-specific HER3 enrichment in basal-like breast cancer is regulated via the GATA2/GATA3-FOXA1 axis.Cancer Lett2025https://conductscience.org/library/papers/40907734PubMed
40660203Identification and modulation of a PI3K/AKT/mTOR pathway-targeting microRNA in order to increase colorectal cancer cells radiosensitivity in vitro.BMC Cancer2025https://conductscience.org/library/papers/40660203PubMed
40558287Prognostic Relevance of Inflammatory Cytokines Il-6 and TNF-Alpha in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.Curr Oncol2025https://conductscience.org/library/papers/40558287PubMed
40229646Targeting kinases that regulate programmed cell death: a new therapeutic strategy for breast cancer.J Transl Med2025https://conductscience.org/library/papers/40229646PubMed
39942749Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer Hypoxia.Molecules2025https://conductscience.org/library/papers/39942749PubMed
38717954Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment.Cancer Rep (Hoboken)2024https://conductscience.org/library/papers/38717954PubMed

Download CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38717954

GET https://conductscience.org/api/papers/v1/38717954/references?page=2